Header Logo

Connection

David Moore to Tuberculosis, Multidrug-Resistant

This is a "connection" page, showing publications David Moore has written about Tuberculosis, Multidrug-Resistant.
  1. Prolonged-course tuberculosis treatment or secondary prevention for those at high risk of recurrence? Clin Microbiol Infect. 2022 05; 28(5):631-633.
    View in: PubMed
    Score: 0,658
  2. Transmission of drug-resistant tuberculosis in HIV-endemic settings. Lancet Infect Dis. 2019 03; 19(3):e77-e88.
    View in: PubMed
    Score: 0,132
  3. Genome-wide analysis of multi- and extensively drug-resistant Mycobacterium tuberculosis. Nat Genet. 2018 02; 50(2):307-316.
    View in: PubMed
    Score: 0,124
  4. Good quality locally procured drugs can be as effective as internationally quality assured drugs in treating multi-drug resistant tuberculosis. PLoS One. 2015; 10(4):e0126099.
    View in: PubMed
    Score: 0,103
  5. High prevalence of childhood multi-drug resistant tuberculosis in Johannesburg, South Africa: a cross sectional study. BMC Infect Dis. 2011 Jan 26; 11:28.
    View in: PubMed
    Score: 0,077
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.